Personalis NeXT Personal Dx Cancer Test Gains UKCA Mark for Great Britain
Personalis Inc has achieved United Kingdom Conformity Assessed (UKCA) marking for its NeXT Personal Dx test. The regulatory…
Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Agilent…
Baylor Genetics Presents New Data on Clinical and
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) — Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic…